BSE has notified trading members that 20,79,409 new equity shares of Bajaj Healthcare Limited (Scrip Code: 539872) are listed and permitted to trade on the Exchange with effect from Wednesday, May 20, 2026. These shares were issued at a premium of Rs. 333/- (issue price Rs. 338/-) to Promoter and Non-Promoter on a preferential basis pursuant to conversion of warrants.

Key Points

• 20,79,409 equity shares of Rs. 5/- each issued at a premium of Rs. 333/- (total issue price Rs. 338/-)
• Allotment date: March 18, 2026
• Distribution numbers: 31583253 to 33662661
• ISIN: INE411U01027
• Shares are ranking pari-passu with existing equity shares
• Trading effective from May 20, 2026

Regulatory Changes

No new regulatory changes. This is a routine listing notification under BSE’s Listing Operations for new securities arising from a preferential allotment.

Compliance Requirements

• Trading members are informed to permit trading of these new securities from May 20, 2026
• Lock-in restrictions must be observed as specified below

Important Dates

• Allotment Date: March 18, 2026
• Trading Commencement: May 20, 2026
• Lock-in expiry (11,69,261 shares): November 30, 2026
• Lock-in expiry (9,10,148 shares): November 30, 2027

Impact Assessment

The listing adds approximately 20.79 lakh new shares to the tradable float of Bajaj Healthcare Limited, representing equity dilution for existing shareholders. Of the newly listed shares, 11,69,261 shares (dist. nos. 31583253–32752513) are locked in until November 30, 2026, and 9,10,148 shares (dist. nos. 32752514–33662661) are locked in until November 30, 2027, limiting near-term selling pressure from allottees. The preferential issue at Rs. 338/- per share reflects the pricing at which promoters and non-promoters converted their warrants into equity.